Curated News
By: NewsRamp Editorial Staff
July 30, 2024
Acarix CEO Announces Trading on OTCQB Market in the US
Discuss on Reddit
Discuss on LinkedIn
Discuss on SubstackTLDR
- Trading on the OTCQB Market expands Acarix's investor base and growth potential in the US market.
- Acarix's CADScor System provides non-invasive assessment of coronary artery disease at the point of care, potentially reducing the need for costly diagnostic procedures.
- Acarix's medical devices offer a non-invasive solution that can help healthcare providers save costs and drive commercial success in the US market.
- Acarix's CEO Aamir Mahmood shared news about the company's expansion into the US market and the impact of its medical devices on healthcare.
Impact - Why it Matters
This news matters because it highlights Acarix's expansion into the US market, offering a non-invasive solution for ruling out coronary artery disease, potentially reducing costly and invasive procedures, and outlining the company's focus on saving healthcare costs and driving commercial success.
Summary
Acarix CEO Aamir Mahmood announced that the company has started trading on the OTCQB Market in the US, under the ticker symbol ACIXF. This move allows for a broader investor base to participate in the company’s growth journey, especially in its most important commercial market.
Acarix specializes in medical devices for rapid assessment of coronary artery disease (CAD) at the point of care. Its flagship product, the CADScor System, is CE-approved and FDA DeNovo-cleared, offering a non-invasive solution to help healthcare providers rule out CAD in patients experiencing chest pain, potentially reducing the need for costly and invasive diagnostic procedures.
The company recently secured significant reorders for its CADScor System patches from primary care clinics in the New Orleans and Oklahoma City/Tulsa metro areas. CEO Mahmood outlined the company's focus on top-line growth, reimbursement efforts, and initiating clinical trials, emphasizing the device's potential to save significant healthcare costs and drive commercial success in the US market.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Acarix CEO Announces Trading on OTCQB Market in the US
